0001209191-22-050556.txt : 20220919 0001209191-22-050556.hdr.sgml : 20220919 20220919171416 ACCESSION NUMBER: 0001209191-22-050556 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220916 FILED AS OF DATE: 20220919 DATE AS OF CHANGE: 20220919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OH ANDREW M. CENTRAL INDEX KEY: 0001746614 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37813 FILM NUMBER: 221251301 MAIL ADDRESS: STREET 1: C/O RUBIUS THERAPEUTICS STREET 2: 325 VASSAR ST., STE. 1A CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001556263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453772460 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617-744-1340 MAIL ADDRESS: STREET 1: 35 CAMBRIDGE PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: LS22, Inc. DATE OF NAME CHANGE: 20120815 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-16 0 0001556263 Syros Pharmaceuticals, Inc. SYRS 0001746614 OH ANDREW M. 35 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 1 0 0 0 Common Stock 2022-09-16 4 A 0 8000 0.00 A 8000 D Stock Option (right to buy) 7.349 2022-09-16 4 A 0 12000 0.00 A 2032-09-15 Common Stock 12000 12000 D The option becomes exercisable as to 16.66% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the third anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date. Amounts reported in this Form 4 reflect the 1-for-10 reverse stock split effected by the issuer on September 16, 2022. /s/ Todd Rosenthal, as attorney-in-fact 2022-09-19